Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001493152-25-017820
Filing Date
2025-10-10
Accepted
2025-10-10 17:29:05
Documents
6

Document Format Files

Seq Description Document Type Size
1 PRER14A formprer14a.htm PRER14A 1030572
2 GRAPHIC formpre14a_001.jpg GRAPHIC 5926
3 GRAPHIC image_003.jpg GRAPHIC 44225
4 GRAPHIC image_001.jpg GRAPHIC 5830
5 GRAPHIC proxy_001.jpg GRAPHIC 312754
6 GRAPHIC proxy_002.jpg GRAPHIC 316861
  Complete submission text file 0001493152-25-017820.txt   1976486
Mailing Address C/O ANEBULO PHARMACEUTICALS, INC. 1017 RANCH ROAD 620 SOUTH, SUITE 107 LAKEWAY TX 78734
Business Address C/O ANEBULO PHARMACEUTICALS, INC. 1017 RANCH ROAD 620 SOUTH, SUITE 107 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Filer) CIK: 0001815974 (see all company filings)

EIN.: 851170950 | State of Incorp.: DE | Fiscal Year End: 0630
Type: PRER14A | Act: 34 | File No.: 001-40388 | Film No.: 251388828
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)